Veytics Intelligence
2026-09-21 · Yahoo

Novo Sets Long-Term Targets Ahead of Semaglutide Patent Expirations

Novo Nordisk's (NVO) US-listed shares declined as the Danish drugmaker unveiled its long-term growth PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium news articles. Upgrade Already have a subscription? Sign in

Doc ban tin day du cua Veytics

Chung toi hien cong khai y chinh. Tao tai khoan mien phi de doc toan bo bai viet, luu, thao luan va ket noi voi boi canh thi truong va OSINT.